Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
This study has been completed and results are pending.
Many people in the U.S. suffer from alopecia areata, yet treatment options are limited and sometimes painful. The goal of this study is to test a new medication taken as a pill that acts on the immune system and may reverse hair loss.
New York Presbyterian Hospital
New York, New York